Obsidian to Present Updated Amsoki-cel Melanoma Data at SITC 2026
Obsidian Therapeutics will present updated Phase 1/2 data on amsoki-cel (OBX-115) in advanced melanoma at the SITC 2026 Annual Meeting, per BioSpace.
Topic
Obx 115
Topic
Obx 115
Obsidian to Present Updated Amsoki-cel Phase 1/2 Melanoma Data at SITC 2026
Obsidian Therapeutics will present updated Phase 1/2 data on amsoki-cel (OBX-115), its engineered TIL therapy, in advanced melano…